Colon targeted delivery systems: review of polysaccharides for encapsulation and delivery

Shantha L Kosaraju1

  • 1Food Science Australia, 671 Snydes Rd., Private Bag 16, Werribee, Victoria 3030, Australia. shantha.kosaraju@csiro.au

Insights

Developing colon-targeted delivery systems using natural polymers shows promise for treating colon diseases. These polysaccharide-based systems offer a novel approach for food and nutraceutical formulations, especially for colorectal cancer therapy.

Area of Science:

  • Drug Delivery Systems
  • Polymer Science
  • Gastroenterology

Background:

  • Colon-targeted delivery of bioactives is crucial for treating colon diseases.
  • Previous colon-specific delivery systems have had limited success.
  • The colonic microenvironment and metabolic activity offer opportunities for novel delivery systems.

Purpose of the Study:

  • To review the potential of natural biodegradable polymers for colon targeting.
  • To emphasize polysaccharide-based systems with minimal chemical modification for colon targeting.
  • To explore the application of these systems in food/nutraceutical formulations for colon diseases.

Main Methods:

  • Review of recent research on colon-targeted delivery systems.
  • Focus on natural biodegradable polymers, particularly polysaccharides.
  • Analysis of systems utilizing colonic microenvironment and metabolic activity.

Main Results:

  • Polysaccharide-based systems show significant potential for colon targeting.
  • Minimal chemical modification of polysaccharides is key for effective systems.
  • These systems can be applied to food and nutraceutical formulations.

Conclusions:

  • Novel colon-targeted delivery systems based on natural polysaccharides are promising.
  • These systems offer a viable strategy for managing colon-based diseases like colorectal cancer.
  • Further development in food/nutraceutical applications is anticipated.

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...